Squadron Capital Management LLC
Long book
$250.0M
Q1 2026
Positions
30
Top-10 weight
73%
concentration
Last quarter
+7.2%
SPY +14.8%
Turnover
60%
of book per quarter
Strategy in plain words
auto-generated from filingsSquadron Capital Management LLC is a concentrated fundamental stock-picker, specialised in healthcare (100% of the long book), running a $250.0M US long book across 30 positions.
The portfolio is concentrated: the top 10 names carry 73% of the portfolio. Turnover is high — positions rotate quickly, so individual names matter less than the process. Current anchor positions: RELMADA THERAPEUTICS INC, COGENT BIOSCIENCES INC, KALVISTA PHARMACEUTICALS INC, KODIAK SCIENCES INC, ABIVAX SA-ADR.
We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q4 2025
-0.7%
Q1 2026
+7.2%
Sector allocation
Healthcare 91%
Other 9%
Long book by quarter
What does Squadron Capital own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| RLMD RELMADA THERAPEUTICS INC | Healthcare | 8.5M | $59.0M | 23.6% | +26.5% |
| COGT COGENT BIOSCIENCES INC | Healthcare | 787.5K | $30.3M | 12.1% | +1.0% |
| 4XC1 KALVISTA PHARMACEUTICALS INC | — | 985.1K | $19.8M | 7.9% | +40.7% |
| KOD KODIAK SCIENCES INC | Healthcare | 380.0K | $14.5M | 5.8% | +30.3% |
| EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 350.0K | $11.0M | 4.4% | Held |
| NKTR NEKTAR THERAPEUTICS | Healthcare | 125.0K | $9.0M | 3.6% | New |
| ZNTL ZENTALIS PHARMACEUTICALS INC | Healthcare | 3.6M | $8.5M | 3.4% | New |
| MAZE MAZE THERAPEUTICS INC | Healthcare | 257.5K | $7.7M | 3.1% | -47.4% |
| SCYX SCYNEXIS INC | Healthcare | 7.6M | $7.0M | 2.8% | New |
| RLAY RELAY THERAPEUTICS INC | Healthcare | 672.5K | $6.7M | 2.7% | New |
| CCCC C4 THERAPEUTICS INC | Healthcare | 2.3M | $5.9M | 2.4% | New |
| IKT INHIBIKASE THERAPEUTICS INC | Healthcare | 3.5M | $5.9M | 2.4% | -17.2% |
| PALI PALISADE BIO INC | Healthcare | 3.0M | $5.3M | 2.1% | -33.3% |
| EPRX EUPRAXIA PHARMACEUTICALS INC | Healthcare | 680.0K | $4.9M | 2.0% | +36.0% |
| GHRS GH RESEARCH PLC | Healthcare | 325.0K | $4.6M | 1.8% | +3.2% |
| PMN PROMIS NEUROSCIENCES INC | Healthcare | 325.0K | $4.1M | 1.7% | New |
| LPCN LIPOCINE INC | Healthcare | 450.0K | $3.6M | 1.4% | -15.1% |
| ALXO ALX ONCOLOGY HOLDINGS INC | Healthcare | 1.5M | $2.9M | 1.2% | New |
| CNTX CONTEXT THERAPEUTICS INC | Healthcare | 1.1M | $2.9M | 1.2% | New |
| NXTC NEXTCURE INC | Healthcare | 265.0K | $2.8M | 1.1% | +11.8% |
| SLGL SOL-GEL TECHNOLOGIES LTD | Healthcare | 31.0K | $2.5M | 1.0% | New |
| KTTA PASITHEA THERAPEUTICS CORP | Healthcare | 2.1M | $1.6M | 0.6% | Held |
| TRAW TRAWS PHARMA INC | Healthcare | 511.7K | $936K | 0.4% | -28.3% |
| TXMD THERAPEUTICSMD INC | Healthcare | 420.4K | $849K | 0.3% | New |
| SPRB SPRUCE BIOSCIENCES INC | Healthcare | 12.2K | $797K | 0.3% | -82.6% |
| HOWL WEREWOLF THERAPEUTICS INC | Healthcare | 563.5K | $469K | 0.2% | New |
| NEUP NEUPHORIA THERAPEUTICS INC | Healthcare | 76.7K | $312K | 0.1% | New |